Skip to main content
Hugel, Inc. logo

Hugel, Inc. — Investor Relations & Filings

Ticker · 145020 ISIN · KR7145020004 KO Manufacturing
Filings indexed 499 across all filing types
Latest filing 2025-06-04 Transaction in Own Shar…
Country KR South Korea
Listing KO 145020

About Hugel, Inc.

https://www.hugel-inc.com/

Hugel, Inc. is a global biopharmaceutical company specializing in the medical aesthetics and therapeutics market. The company develops, manufactures, and distributes a portfolio of high-quality products, including its flagship botulinum toxin type A formulations, known commercially as Botulax and Letybo. Its product line also features a range of hyaluronic acid (HA) fillers and PDO threads. Recognized as a leader in its field, Hugel is focused on providing innovative, efficient, and proven solutions to medical professionals worldwide. The company is committed to advancing aesthetic medicine through continuous research and development to create effective and reliable treatments.

Recent filings

Filing Released Lang Actions
신탁계약해지결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on the Termination of a Trust Agreement' (신탁계약해지결과보고서) filed by Hugel Co., Ltd. with the Financial Supervisory Service (FSS) of South Korea. It details the termination of a stock repurchase trust contract and the subsequent transfer of shares back to the company's own account. This type of filing, which reports on the status and conclusion of share repurchase activities, falls under the category of 'Transaction in Own Shares' (POS).
2025-06-04 Korean
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Major Shareholding Notification Classification · 100% confidence The document is a 'Corporate Group Status Disclosure' (기업집단현황공시) filed by Hugel Co., Ltd. under the GS Group. This type of filing is a mandatory regulatory disclosure in South Korea, detailing corporate structure, financial status, board composition, shareholding, and inter-company transactions. Since it does not fit into specific categories like 10-K, IR, or AGM-R, and is a formal regulatory submission, it is classified as a Regulatory Filing (RNS).
2025-05-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details the shareholding status, changes in ownership, and contractual relationships of a major shareholder (Aphrodite Acquisition Holdings LLC) in Hugel Co., Ltd. This type of filing is specifically categorized as a Major Shareholding Notification (MRQ) in the provided schema.
2025-05-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory requirement for directors and major shareholders to disclose their personal share transactions (insider trading). Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2025-05-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS). It details the acquisition of shares by a director (Cha Suk-yong) of Hugel Inc. through the exercise of stock options. This type of filing is a standard regulatory disclosure for insider transactions, which falls under the 'Director's Dealing' category.
2025-05-19 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Hugel, Inc. covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial information, business operations, management discussions, and capital structure data, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.